Chemoinformaics analysis of (2r,3r,5s,6r)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triol
| Molecular Weight | 193.199 | nRot | 2 |
| Heavy Atom Molecular Weight | 178.079 | nRig | 6 |
| Exact Molecular Weight | 193.095 | nRing | 1 |
| Solubility: LogS | 0.043 | nHRing | 1 |
| Solubility: LogP | -2.496 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 26.8019 |
| nHD | 6 | BPOL | 15.6181 |
| QED | 0.27 |
| Synth | 4.115 |
| Natural Product Likeliness | 1.836 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.335 |
| HIA | 0.914 |
| CACO-2 | -5.266 |
| MDCK | 0.000532417 |
| BBB | 0.212 |
| PPB | 0.135026 |
| VDSS | 0.367 |
| FU | 0.829968 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.15 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.135 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.127 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.01 |
| CL | 1.71 |
| T12 | 0.766 |
| hERG | 0.047 |
| Ames | 0.048 |
| ROA | 0.001 |
| SkinSen | 0.211 |
| Carcinogencity | 0.014 |
| EI | 0.127 |
| Respiratory | 0.076 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.901489 |